Where this device will fit in with other emerging options remains to be seen, but it might hold an advantage in large annuli.

The novel dissolvable therapy had a 93.2% probability of being cost-effective at a modest willingness-to-pay level.

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...